Furthermore, Liu and co‐workers used CAR T cells with antigen modification to target the AFP gene in AFP+ liver cancer cells.[127] The results showed obvious tumor growth suppression in vivo and provided a targeting strategy for CRISPR‐based applications. Here, AFP is linked to liver cancer.